Filter
1631
Filtered Results: 1631
Text search:
assays
Featured
Recommendations
209
New Publications
428
Language
Document type
No document type
894
Guidelines
332
Studies & Reports
212
Manuals
72
Strategic & Response Plan
46
Fact sheets
45
Training Material
14
Situation Updates
7
Resource Platforms
5
Infographics
2
Brochures
1
Online Courses
1
Countries / Regions
India
100
Global
46
Western and Central Europe
46
South Africa
33
Tanzania
28
Germany
26
Eastern Europe
26
Latin America and the Carribbean
23
Kenya
22
Nigeria
22
Brazil
22
Nepal
21
Africa
20
Ethiopia
20
Uganda
19
Russia
18
Sierra Leone
17
Syria
17
Malawi
17
Ukraine
16
Liberia
16
Congo, Democratic Republic of
15
Zambia
15
Myanmar / Burma
15
Mozambique
14
Colombia
13
Ghana
13
Rwanda
13
Bangladesh
13
West and Central Africa
10
Namibia
10
Haiti
9
Middle East and North Africa
9
East and Southern Africa
9
Argentina
9
Philippines
8
Venezuela
8
South–East Asia Region
8
Lesotho
7
Senegal
7
Zimbabwe
7
Cambodia
7
Asia
7
Central African Republic
7
Burkina Faso
6
Eastern Europe and Central Asia
6
Indonesia
6
Madagascar
6
Benin
5
Cameroon
5
Peru
5
Yemen
5
Angola
5
El Salvador
4
Chile
4
USA
4
Mali
4
Somalia
4
Eswatini/ Swaziland
4
Mexico
3
Niger
3
Afghanistan
3
Jordan
3
Saudi Arabia
3
Western Pacific Region
3
Paraguay
3
Bolivia
3
Lebanon
3
Sri Lanka
3
Sudan
3
Libya
3
Botswana
3
Ecuador
3
Pakistan
3
Timor Leste/ East Timor
2
China
2
Iran
2
Qatar
2
Guinea
2
Armenia
2
Dominican Republic
2
Spain
2
Côte d’Ivoire / Ivory Coast
2
Moldova
2
Egypt
2
Palestine
2
Georgia
2
Chad
2
Bhutan
2
Iraq
2
North Macedonia
1
Tajikistan
1
North Korea
1
Switzerland
1
Turkey
1
Kazakhstan
1
Albania
1
Estonia
1
Congo-Brazzaville
1
Morocco
1
Mongolia
1
Mauritania
1
Guinea-Bissau
1
North America
1
Uruguay
1
Jamaica
1
France
1
Tunisia
1
Portugal
1
Belarus
1
Israel
1
Southern Africa
1
Vietnam
1
Papua New Guinea
1
Nicaragua
1
Djibouti
1
Romania
1
Honduras
1
South Sudan
1
Cuba
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
550
Clinical Guidelines
245
Pharmacy & Technologies
67
Public Health
61
Key Resources
36
Women & Child Health
25
Capacity Building
7
Toolboxes
TB
315
COVID-19
179
HIV
176
NTDs
134
Rapid Response
82
Ebola & Marburg
51
AMR
32
Refugee
30
Zika
30
Pharmacy
29
Conflict
26
Mental Health
23
NCDs
22
Planetary Health
16
Polio
13
Natural Hazards
10
Caregiver
9
Specific Hazards
8
Cholera
4
Health Financing Toolbox
4
Disability
2
Global Health Education
2
Qualitative assay for use on the cobas®6800/8800 Systems. For in vitro diagnostic use
Interferon-γ Assays - Description and Assessment of a New Tool in the Diagnosis of Tuberculosis.
Haür B et al. Interferon-γ-Tests in der ...Pneumologie 2006; 60: 29-44
WHO working group on HIV incidence assays meeting report
10–11 December 2015
Glion, Switzerland
UNAIDS/WHO working group on global HIV/AIDS and STI surveillance
WHO/HIV/2017.03
Many in-house and commercial assays that detect the COVID-19 virus have been developed or are currently under development. Many of these molecular assays are currently being validated in partner laboratories. An overview of assays that have applied to FIND for participation in their assay assessment...
Annex to Selection and use of Ebola in vitro diagnostic assays
This guidance is intended to be used by programme managers following the decision to introduce human papillomavirus (HPV) virological testing as a screening assay in their national cervical cancer prevention and control programme. The guidance includes a step-by-step process to be followed after the...
Laboratory biosafety guidance related to coronavirus disease (COVID-19): Interim guidance, 28 January 2021
recommended
The latest update (28 January 2021) includes the following addition and revision:
biosafety aspects for working with antigen-detecting rapid diagnostic test;
handling new variants of SARS-CoV-2 in the laboratory;
updated assay decontamination before disposal;
personal protectiv...
Zika and dengue viruses remain significant public health threats. These viruses share the same Aedes (Stegomyia) mosquito vectors and geographic distributions but infections cannot be readily distinguished clinically and need to be differentiated from each other, and from other circulating arboviral...
Marburg and Ebola are filoviruses that cause hemorrhage, multiple organ failure, and high mortality rates. Diagnosis is with enzyme-linked immunosorbent assay, polymerase chain reaction (PCR), or electron microscopy. Treatment is supportive. Strict isolation and quarantine measures are necessary to ...
Chagas disease is caused by Trypanosoma cruzi. Infection is transmitted to humans when bitten by Triatominae (reduviid, kissing, or assassin) bugs in South and Central America, Mexico, and very rarely in the US. Less commonly, T. cruzi is transmitted via ingestion of sugar cane juice or food contami...
The latest update (28 January 2021) includes the following addition and revision:
biosafety aspects for working with antigen-detecting rapid diagnostic test;
handling new variants of SARS-CoV-2 in the laboratory;
updated assay decontamination before disposal;
personal protectiv...
The latest update (28 January 2021) includes the following addition and revision:
biosafety aspects for working with antigen-detecting rapid diagnostic test;
handling new variants of SARS-CoV-2 in the laboratory;
updated assay decontamination before disposal;
personal protectiv...
Three classess of tests are now recommended in the latest consolidated guideles on tests for tuberculosis infection. It includes for the first-time a new class of Mycobacterium tuberculosis antigen-based skin tests (TBSTs), and the two existing classes of tests: the tuberculin skin test (TST) and t...
Parasites & Vectors volume 11, Article number: 264 (2018)
Dengue creates a staggering epidemiological and economic burden for endemic countries. Without a specific therapy and with a commercial vaccine that presents some problems relative to its full effectiveness, initiatives to improve vector...
Updated recommendations on simplified service delivery and diagnostics for hepatitis C infection
recommended
Policy Brief. 24 June 2022. This policy brief, one of two on the updated hepatitis C (HCV) guidelines, focuses on the new recommendations on simplified service delivery for a public health approach to HCV testing, care and treatment. These recommendations include decentralization, integration and ta...
n light of the potential risk posed by SARS-CoV-2 variants, in January 2021 WHO organized an ad hoc consultation to discuss the development of an R&D agenda in response to existing and emerging SARS-CoV-2 variants.
The key objectives were to identify the critical research questions related to var...
2nd edition. WHO's recommendation has not changed: the standard WHO susceptibility tests should remain a primary method by which resistance is detected. However, it was considered necessary to update the existing resistance-monitoring procedures to also highlight the need for operationally meaningfu...
These guidelines provide updated evidence-based recommendations on the priority HCV-related topics from the 2018 WHO Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C infection and the 2017 WHO Guidelines on hepatitis B and C testing. These priority areas are:
...
This document aims to provide interim guidance for microbiology and virology experts, other laboratory professionals, laboratory managers, infectious disease programme managers, public health professionals and other stakeholders that provide primary, confirmatory or advanced testing for SARS-CoV-2, ...
